|
Delayed
Sao Paulo
12:52:51 2026-10-23 EDT
|
5-day change | 1st Jan Change | ||
| 4.460 BRL | -6.11% |
|
+2.53% | -25.42% |
| Market Cap | 1.92B 9.67B 1.71B 1.58B 1.44B 2.69B 182B 2.73B 19.06B 7.55B 95.51B 7.21B 7.05B 301B | P/E 2026 * |
6.12x | P/E 2027 * | 79.4x |
|---|---|---|---|---|---|
| Enterprise Value | 1.68B 8.44B 1.5B 1.38B 1.25B 2.34B 159B 2.38B 16.64B 6.59B 83.36B 6.29B 6.16B 263B | EV / Sales 2026 * |
0.91x | EV / Sales 2027 * | 0.94x |
| Free-Float |
94.53% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Sarepta Therapeutics, Inc.
| 1 day | -6.11% | ||
| 1 week | +2.53% | ||
| Current month | -5.91% | ||
| 1 month | -9.35% | ||
| 3 months | +10.12% | ||
| 6 months | -10.62% | ||
| Current year | -25.42% |
| 1 week | 4.33 |  | 4.75 |
| 1 month | 4.14 | | 4.97 |
| Current year | 3.75 | | 6.4 |
| 1 year | 3.75 | | 6.65 |
| 3 years | 2.88 | | 45.78 |
| 5 years | 2.88 | | 45.78 |
| 10 years | 2.88 | | 45.78 |
| Manager | Title | Age | Since |
|---|---|---|---|
Michael Severino
CEO | Chief Executive Officer | 60 | 2026-07-27 |
Ryan Wong
DFI | Director of Finance/CFO | 47 | 2025-07-15 |
Ian Estepan
DFI | Director of Finance/CFO | 50 | 2020-12-13 |
| Director | Title | Age | Since |
|---|---|---|---|
M. Wilsey
CHM | Chairman | 73 | 2015-04-15 |
| Director/Board Member | 87 | 2010-05-31 | |
Rick Barry
BRD | Director/Board Member | 67 | 2015-06-01 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -6.11% | +2.53% | - | - | 1.96B | |
| -2.43% | +1.54% | +55.46% | +121.34% | 1,165B | |
| -1.68% | +2.93% | +36.67% | +73.76% | 645B | |
| +0.25% | +0.10% | +25.17% | +97.40% | 504B | |
| -0.31% | +3.09% | +43.92% | +64.55% | 380B | |
| -1.56% | -0.93% | +65.86% | +39.91% | 363B | |
| -0.68% | +2.65% | +22.46% | +51.48% | 297B | |
| -1.20% | +3.04% | +2.62% | +26.97% | 269B | |
| -1.17% | +2.19% | +50.90% | +61.86% | 237B | |
| -0.06% | +0.80% | +30.40% | +102.99% | 195B | |
| Average | -1.54% | +2.54% | +37.05% | +71.14% | 450.61B | |
| Weighted average by Cap. | -1.34% | +3.17% | +41.16% | +82.44% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 1.83B 9.23B 1.64B 1.51B 1.37B 2.56B 174B 2.6B 18.19B 7.2B 91.13B 6.88B 6.73B 287B | 1.38B 6.96B 1.23B 1.14B 1.03B 1.93B 131B 1.96B 13.71B 5.43B 68.67B 5.18B 5.07B 217B |
| Net income | 340M 1.71B 303M 280M 254M 475M 32.25B 483M 3.37B 1.34B 16.9B 1.27B 1.25B 53.27B | -6.15M -30.96M -5.49M -5.07M -4.6M -8.6M -583M -8.74M -61.02M -24.16M -306M -23.07M -22.58M -964M |
| Net Debt | -244M -1.23B -218M -202M -183M -342M -23.19B -347M -2.43B -960M -12.15B -917M -897M -38.31B | -618M -3.11B -551M -509M -462M -864M -58.62B -878M -6.13B -2.43B -30.71B -2.32B -2.27B -96.84B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-10-23 | R$4.460 | -6.11% | 12,085 |
| 26-10-22 | R$4.750 | +1.50% | 3 |
| 26-10-21 | R$4.680 | -1.47% | 7 |
| 26-10-20 | R$4.750 | +9.70% | 3,003 |
| 26-10-19 | R$4.330 | -0.46% | 11 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- SRPT Stock
- S1RP34 Stock
Select your edition
All financial news and data tailored to specific country editions
